Month: January 2017

Study suggests enzyme safely starves cancer cells

A University of Texas at Austin research team that includes Dr. John DiGiovanni, professor of pharmacology and toxicology, has engineered an enzyme that safely treats prostate and breast cancer in animals, and also lengthens the lifespan of models that develop

Pharmaceutics article garners journal honor

A recently published paper “Solubility Advantage (and Disadvantage) of Pharmaceutical Amorphous Solid Dispersions” co-authored by Siyuan Huang Ph.D. and R. O. Williams III and collaborators from Genentech was recognized for its “Most Original and Most Significant Scientific Findings” by editors